Klinik und Poliklinik für Innere Medizin III, Klinikum rechts der Isar der TU München

Munich 81675

0 studies enrolling now · 1 studies all time

What they study most

Advanced Systemic Mastocytosis, Aggressive Systemic Mastocytosis, Mast Cell Leukemia, Systemic Mastocytosis With an Associated Hematologic Neoplasm

Studies at this site

• (PATHFINDER) Study to Evaluate Efficacy and Safety of Avapritinib (BLU-285), A Selective KIT Mutation-targeted Tyrosine Kinase Inhibitor, in Patients With Advanced Systemic Mastocytosis — Completed